FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-003328-35-FR
Enrollment
Unknown
Registered
2015-06-22
Start date
2014-03-13
Completion date
Unknown
Last updated
2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 18.0 Level: PT Classification code 10038528 Term: Renal stone removal System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: Urorec 8 mg Product Name: Urorec Pharmaceutical Form: Capsule INN or Proposed INN: Silodosin CAS Number: 160970-54-7 Other descriptive name: SILODOSIN

Sponsors

Centre Hospitalier Départemental Vendée
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 160 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactAUZANNEAU Lucie

Centre Hospitalier Départemental Vendée

lucie.auzanneau@chd-vendee.fr+330251446380

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026